REGEnLIFE

📍 Montpellier, France🗓 Founded 2016👥 8 employees💰 Last funded Feb 2023
Medical Equipment Manufacturing🌐 regenlife.com
Website LinkedIn
REGEnLIFE is an innovative company developing cutting-edge therapy for neurodegenerative disorders. Our company supports a non-invasive medical approach based on physical sciences. Our mission is to develop innovative and responsible technologies to face up to medical challenges and public health needs. Our goal is to provide to healthcare professionals a technology able to alter the progression of neurodegenerative diseases, in order to improve the health and quality of life to promote a healthy aging process. Our technology consists in a novel medical device dedicated to people living with neurodegenerative diseases, specifically Alzheimer-type dementia.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2016
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in REGEnLIFE?
REGEnLIFE has 1 investors on record on gritt.io and 1 late-stage investors.
When did REGEnLIFE last raise funding?
The most recent investment in REGEnLIFE recorded on gritt.io was in February 2023.
When was REGEnLIFE founded?
REGEnLIFE was founded in 2016.
What industry is REGEnLIFE in?
REGEnLIFE operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is REGEnLIFE based?
REGEnLIFE is headquartered in Montpellier, France.